Anthropic's Claude now autonomously leads 26% of its own R&D work, up from under 1% earlier in 2026
Anthropic reported Claude now independently leads ~26% of measured AI R&D tasks, with >90% involving human-AI collaboration. New partnerships announced: Accenture for frontier AI evaluation and Novo Nordisk for drug discovery workflows using Claude.
TLDR
Demonstrates accelerating 'AI building AI' capabilities and agentic workflows. Partnerships, particularly Accenture's independent evaluation role, align with calls for third-party oversight of frontier AI development amid broader governance debates in the industry.
Combined views
210.9K
1 Source, first seen 3h ago
Anthropic's Claude now autonomously leads 26% of its own R&D work, up from under 1% earlier in 2026
Anthropic reported Claude now independently leads ~26% of measured AI R&D tasks, with >90% involving human-AI collaboration. New partnerships announced: Accenture for frontier AI evaluation and Novo Nordisk for drug discovery workflows using Claude.
TLDR
Demonstrates accelerating 'AI building AI' capabilities and agentic workflows. Partnerships, particularly Accenture's independent evaluation role, align with calls for third-party oversight of frontier AI development amid broader governance debates in the industry.